The post Evenepoel, Reusser Open World Road Championships With Time Trial Wins appeared on BitcoinEthereumNews.com. Belgian Remco Evenepoel celebrates and shows the number of his victories, three on a row, on the podium of the Men Elite Individual Time Trial race (40,8km) at the cycling road world championships, in Kigali, Rwanda, Sunday 21 September 2025. The 2025 UCI Road World Championships take place from 21 to 28 September in Kigali, Rwanda. BELGA PHOTO DIRK WAEM (Photo by DIRK WAEM / BELGA MAG / Belga via AFP) (Photo by DIRK WAEM/BELGA MAG/AFP via Getty Images) BELGA MAG/AFP via Getty Images Remco Evenepoel won his third-straight individual time trial at the 2025 UCI World Road Cycling Championships in Kigali, Rwanda, while Marlen Reusser won the first world title of her career in the women’s event. Evenepoel made a statement with his race, finishing the rolling 40.6-kilometer circuit in 49 minutes and 46 seconds. He was the only rider to crack the 50-minute mark, beating Australia’s Jay Vine by one minute and 14 seconds. Belgium put two riders on the podium, as Evenepoel’s teammate Ilan van Wilder put in the performance of his life to take bronze in his first time racing an individual time trial on the World Championship stage. The women’s race was a 31.2-kilometer route that was similarly difficult up-and-down to the men’s edition. A three-time European time trial champion, Reusser claimed her first rainbow jersey by finishing in 43 minutes and nine seconds, winning by 51.89 seconds. Behind her, Dutch teammates Anna van der Breggen and Demi Vollering took silver and bronze. Evenepoel Catches Pogačar In Closing Kilometers KIGALI, RWANDA – SEPTEMBER 21: Remco Evenepoel of Team Belgium competes during 98th UCI Cycling World Championships Kigali 2025 – Men Elite Individual Time Trial a 40.6km race from Kigali to Kigali on September 21, 2025 in Kigali, Rwanda. (Photo by Dario Belingheri/Getty Images) Getty Images… The post Evenepoel, Reusser Open World Road Championships With Time Trial Wins appeared on BitcoinEthereumNews.com. Belgian Remco Evenepoel celebrates and shows the number of his victories, three on a row, on the podium of the Men Elite Individual Time Trial race (40,8km) at the cycling road world championships, in Kigali, Rwanda, Sunday 21 September 2025. The 2025 UCI Road World Championships take place from 21 to 28 September in Kigali, Rwanda. BELGA PHOTO DIRK WAEM (Photo by DIRK WAEM / BELGA MAG / Belga via AFP) (Photo by DIRK WAEM/BELGA MAG/AFP via Getty Images) BELGA MAG/AFP via Getty Images Remco Evenepoel won his third-straight individual time trial at the 2025 UCI World Road Cycling Championships in Kigali, Rwanda, while Marlen Reusser won the first world title of her career in the women’s event. Evenepoel made a statement with his race, finishing the rolling 40.6-kilometer circuit in 49 minutes and 46 seconds. He was the only rider to crack the 50-minute mark, beating Australia’s Jay Vine by one minute and 14 seconds. Belgium put two riders on the podium, as Evenepoel’s teammate Ilan van Wilder put in the performance of his life to take bronze in his first time racing an individual time trial on the World Championship stage. The women’s race was a 31.2-kilometer route that was similarly difficult up-and-down to the men’s edition. A three-time European time trial champion, Reusser claimed her first rainbow jersey by finishing in 43 minutes and nine seconds, winning by 51.89 seconds. Behind her, Dutch teammates Anna van der Breggen and Demi Vollering took silver and bronze. Evenepoel Catches Pogačar In Closing Kilometers KIGALI, RWANDA – SEPTEMBER 21: Remco Evenepoel of Team Belgium competes during 98th UCI Cycling World Championships Kigali 2025 – Men Elite Individual Time Trial a 40.6km race from Kigali to Kigali on September 21, 2025 in Kigali, Rwanda. (Photo by Dario Belingheri/Getty Images) Getty Images…

Evenepoel, Reusser Open World Road Championships With Time Trial Wins

2025/09/22 04:16

Belgian Remco Evenepoel celebrates and shows the number of his victories, three on a row, on the podium of the Men Elite Individual Time Trial race (40,8km) at the cycling road world championships, in Kigali, Rwanda, Sunday 21 September 2025. The 2025 UCI Road World Championships take place from 21 to 28 September in Kigali, Rwanda. BELGA PHOTO DIRK WAEM (Photo by DIRK WAEM / BELGA MAG / Belga via AFP) (Photo by DIRK WAEM/BELGA MAG/AFP via Getty Images)

BELGA MAG/AFP via Getty Images

Remco Evenepoel won his third-straight individual time trial at the 2025 UCI World Road Cycling Championships in Kigali, Rwanda, while Marlen Reusser won the first world title of her career in the women’s event.

Evenepoel made a statement with his race, finishing the rolling 40.6-kilometer circuit in 49 minutes and 46 seconds. He was the only rider to crack the 50-minute mark, beating Australia’s Jay Vine by one minute and 14 seconds. Belgium put two riders on the podium, as Evenepoel’s teammate Ilan van Wilder put in the performance of his life to take bronze in his first time racing an individual time trial on the World Championship stage.

The women’s race was a 31.2-kilometer route that was similarly difficult up-and-down to the men’s edition. A three-time European time trial champion, Reusser claimed her first rainbow jersey by finishing in 43 minutes and nine seconds, winning by 51.89 seconds. Behind her, Dutch teammates Anna van der Breggen and Demi Vollering took silver and bronze.

Evenepoel Catches Pogačar In Closing Kilometers

KIGALI, RWANDA – SEPTEMBER 21: Remco Evenepoel of Team Belgium competes during 98th UCI Cycling World Championships Kigali 2025 – Men Elite Individual Time Trial a 40.6km race from Kigali to Kigali on September 21, 2025 in Kigali, Rwanda. (Photo by Dario Belingheri/Getty Images)

Getty Images

Heading into Sunday’s race, four-time Tour de France winner Tadej Pogačar was seen as Evenepoel’s main challenger for the world title. Pogačar typically excels at the time trials that come in the middle of Grand Tour fatigue—he earned his first Tour de France title by overtaking Primož Roglič in an individual time trial on the race’s penultimate day. He has not been as successful in one day time trials, but the combination of the hilly route, the competition field, and Evenpoel’s struggles this season made Pogačar a real contender in the race.

Instead, the enduring image from this event will be Evenepoel passing Pogačar on the cobbled climb up the Côte de Kimihurura about a kilometer from the finish. Pogačar started the race two minutes and thirty seconds ahead of the defending champion, but Evenepoel consistently ate into Pogačar’s advantage, flying through the checkpoints well ahead of Pogačar’s pace.

“The first climb was quite hard, together with the last two, but I really pushed it there and after that saw I had quite a big gap, so I just wanted to keep a pace that I could hold onto until I went flat out on the last climb,” said Evenepoel. “It was so hard to really push through [the cobbles] at the end, but to win is the most important.”

The image is the inverse of what spectators saw during the second time trial of this year’s Tour de France, when two-time winner Jonas Vingegaard overtook the struggling Evenepoel in the final meters. Evenepoel finished third at the 2024 Tour de France but his training this season was derailed after crashes in December and April. He won the stage five individual time trial before abandoning on stage 14, revealing later he had been riding with a broken rib.

Evenepoel also made headlines this summer as his current trade team, Soudal-Quickstep, released him from his contract a year early to allow his transfer to Red Bull-Bora-Hansgrohe for next season.

Pogačar tried to follow Evenepoel’s final push but was unable to keep contact with the Belgian. He finished two minutes and 37 seconds behind Evenepoel in fourth place, a second off the podium.

Pogačar and the rest of the riders will now shift focus to next Sunday’s elite men’s road race. Pogačar is eyeing a second consecutive title and another year in the rainbow jersey. Evenepoel will also take the start, looking to win the road race world title for the first time since 2022. Last summer, Evenepoel became the first male cyclist to win the road race and time trial at a single Olympic Games.

Reusser Overcomes Illness For First World Title

KIGALI, RWANDA – SEPTEMBER 21: Gold medalist Marlen Reusser of Team Switzerland celebrates winning during the medal ceremony after the 98th UCI Cycling World Championships Kigali 2025 – Women Elite Individual Time Trial a 31.2km race from Kigali to Kigali on September 21, 2025 in Kigali, Rwanda. (Photo by Alex Whitehead – Pool/Getty Images)

Getty Images

Reusser, 34, began her season strong, winning the women’s Giro d’Italia—one of the three Grand Tours—along the Tour de Suisse and Vuelta a Burgos stage races. The Swiss rider arrived at the 2025 Tour de France Femmes as a pre-race favorite but abandoned during first stage after suffering with a stomach bug.

After she revealed before the race that another illness affected her preparation for the UCI Road World Championships, it seemed like it would be the latest addition to a string of bad luck that has kept one of the best time trialists in the women’s World Tour peloton that has prevented her from winning the world title.

“It’s up and down, but it’s not unique with me,” she said. “Some have even lower downs, and they get stuck in a down and you don’t hear anything from them anymore. So that’s why you’re aware, because I go also over my highs and you see me performing well.”

Reusser reversed the script during the individual time trial, peaking at the right moment to overcome Dutch rivals van der Breggen and Vollering by over 50 seconds.

“Of course this is super special for me,” she said after the race. “I came into the sport as a super talent time trialist, I won so many time trials, I actually beat many of the rider who were world champ in other races, but never in the World Championships or the Olympic Games, so for me this was a knacknuss we say in German – a nut you have to open hard. So I’m happy I opened it today.”

Van der Breggen, who came out of retirement and returned World Tour racing this season, was the first of the three medalists to start. She completed the course in 44 minutes and one second, which made her the clubhouse leader by over two minutes.

When it was Reusser’s turn she was the fastest to the first checkpoint by nine seconds and was 28 seconds ahead of van der Breggen at the second time check. She gave back about five seconds at the penultimate time check but powered through with a sensational close that exploded her advantage.

Vollering was only a second down on Reusser at the first time check but was 29 seconds slower at the second. Reusser had just crossed the finish line and that check on Vollering swung the momentum heavily in her favor. Vollering took bronze one minute and five seconds behind Reusser.

The women’s elite road race will take place Saturday, September 27, the day before the men’s race caps off Africa’s first time hosting the senior UCI World Road Championships.

Source: https://www.forbes.com/sites/sophiekaufman/2025/09/21/evenepoel-reusser-open-world-road-championships-with-time-trial-wins/

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.
Share Insights

You May Also Like

New Viral Presale on XRPL: DeXRP Surpassed $6.4 Million

New Viral Presale on XRPL: DeXRP Surpassed $6.4 Million

The post New Viral Presale on XRPL: DeXRP Surpassed $6.4 Million  appeared on BitcoinEthereumNews.com. One of the most talked-about ecosystems in the cryptocurrency space is the XRP Ledger (XRPL), and DeXRP, the first Presale on XRPL, recently made headlines for its growth story. Attracting over 9,300 investors globally, the project has now raised over $6.4 million and is rapidly emerging as one of the most viral cryptocurrency launches of 2025. By integrating AMM and Order Book trading with a cutting-edge LP system and an open voting process for holders, DeXRP hopes to establish itself as the preferred trading destination for the XRPL community. What is DeXRP?  As the first decentralized exchange (DEX) based on XRPL, DeXRP is taking center stage as XRP continues to solidify its place in the global market. Massive expectation has been generated by the combination of DeXRP’s ambition for an advanced trading platform and XRPL’s established infrastructure, which is renowned for its quick transactions, cheap fees, and institutional-ready capabilities. In contrast to a lot of speculative presales, DeXRP’s development shows both institutional interest and community-driven momentum. Its early achievement of the $6.4 million milestone demonstrates how rapidly investors are realizing its potential. DeXRP Presale Success More than 9,300 distinct wallets have already joined the DeXRP presale, indicating a high level of interest from around the world. A crucial aspect is highlighted by the volume and variety of participation: DeXRP is not merely a niche project; rather, it is emerging as a major force in the XRPL ecosystem. DeXRP’s recent collaborations with WOW Earn and Micro3, as well as its sponsorship of the WOW Summit in Hong Kong, are also contributing factors to this uptick in investor confidence. These actions are blatant attempts to increase the company’s awareness among institutional players and crypto-native groups. The Forbes article summed it up: DeXRP is embedding credibility where others chase hype, marking it as…
Share
2025/09/18 20:14
Share
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
2025/09/18 05:26
Share